EMYLCAMATE

Related products

• 

  Rated 0 out of 5

  ETAZENE .HCL

  €60.00 – €27,800.00

  Iupac name: N,N-diethyl-2-(2-(4-ethoxybenzyl)-1H-benzo[d]imidazol-1-yl)ethan-1-amine

  Chemical Formula: C22H29N3O

  Molecular Weight: 351.494 g•mol−1

   

  Desnitroetonitazene (Etazen, Etazene, Etazone) is a benzimidazole derived opioid analgesic drug, which was originally developed in the late 1950s alongside etonitazene and a range of related derivatives. It is many times less potent than etonitazene itself, but still 70x more potent than morphine in animal studies. Desnitroetonitazene has been sold as a designer drug, first being identified in both Poland and Finland in March 2020…

   

  This product is intended for research and forensic applications.

  Select options

  Quick View
• 

  Rated 0 out of 5

  Buy codeine in Germany

  Consider the possibility of misuse before prescribing

  The possibility of misuse should be considered if warning signs are present, such as patients requesting an analgesic without a clear indication or insistently requesting codeine, higher doses or a stronger opioid, asking for early repeats or reporting losing medicines or prescriptions.

  Read more

  Quick View
• 

  Rated 0 out of 5

  O-DSMT .HCL

  €280.00 – €8,000.00

  Emylcamate (marketed as Striatran by Merck) is an anxiolytic and muscle relaxant. It was patented in the US in 1961 (US Patent 2,972,564) and advertised for the treatment of anxiety and tension. It was claimed to be superior to meprobamate, which was the market leader at the time. It is no longer prescribed. A study of the drug’s effects in mice was done in 1959. It concluded that at 50 mg/kg emylcamate gave a 63% decrease in motor activity compared with meprobamate’s 32% decrease, a doubling in effective potency. The therapeutic index in mice was also established: ED50 (mg/kg):123 Emylcamate also has a faster intra-parenteral onset then meprobamate, 3 minutes compared with 35

  This product is intended for research and forensic applications

  Select options

  Quick View
• 

  Rated 0 out of 5

  BUTONITAZENE .HCL

  €70.00 – €27,800.00

  BUTONITAZENE .HCL:

  Formal Name ：2-(2-(4-butoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)-N,N-diethylethan-1-amine

  Chemical Formula: C24H32N4O3

  Molecular Weight: 424.55

  BUTONITAZENE is an analgesic drug related to etonitazene, which was first reported in 1957,and has been shown to have approximately 50 times the potency of morphine by central routes of administration,but if used orally it has been shown to have approximately 5 times the potency of morphine.

   

  Its effects are similar to other opioids like fent and her, including analgesia, euphoria, sleepiness. Adverse effects include vomiting, and respiratory depression that can potentially be fatal. Because of high dependency potential and dangerous adverse effects it has never been introduced in pharmacotherapy.

   

  This product is intended for research and forensic applications.

  Select options

  Quick View
• 

  Rated 0 out of 5

  2-METHYL-AP-237.HCL

  €280.00 – €7,000.00

  Emylcamate (marketed as Striatran by Merck) is an anxiolytic and muscle relaxant. It was patented in the US in 1961 (US Patent 2,972,564) and advertised for the treatment of anxiety and tension. It was claimed to be superior to meprobamate, which was the market leader at the time. It is no longer prescribed. A study of the drug’s effects in mice was done in 1959. It concluded that at 50 mg/kg emylcamate gave a 63% decrease in motor activity compared with meprobamate’s 32% decrease, a doubling in effective potency. The therapeutic index in mice was also established: ED50 (mg/kg):123 Emylcamate also has a faster intra-parenteral onset then meprobamate, 3 minutes compared with 35

  This product is intended for research and forensic applications

  Select options

  Quick View